Genetic Variants at 12p11 and 12q24 Are Associated with Breast Cancer Risk in a Chinese Population

• Zhenzhen Qin ,

  Contributed equally to this work with: Zhenzhen Qin, Yanru Wang

  Affiliations State Key Laboratory of Reproductive Medicine, Institute of Toxicology, Nanjing Medical University, Nanjing, China, MOE Key Laboratory of Modern Toxicology, Department of Epidemiology and Biostatistics, School of Public Health, Nanjing Medical University, Nanjing, China, Section of Clinical Epidemiology, Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Cancer Center, Nanjing Medical University, Nanjing, China

  ⨯
• Yanru Wang ,

  Contributed equally to this work with: Zhenzhen Qin, Yanru Wang

  Affiliation Department of Medical Oncology, Jinling Hospital, Southern Medical University, Nanjing, China

  ⨯
• Songyu Cao,

  Affiliation MOE Key Laboratory of Modern Toxicology, Department of Epidemiology and Biostatistics, School of Public Health, Nanjing Medical University, Nanjing, China

  ⨯
• Yisha He,

  Affiliation MOE Key Laboratory of Modern Toxicology, Department of Epidemiology and Biostatistics, School of Public Health, Nanjing Medical University, Nanjing, China

  ⨯
• Hongxia Ma,

  Affiliations State Key Laboratory of Reproductive Medicine, Institute of Toxicology, Nanjing Medical University, Nanjing, China, MOE Key Laboratory of Modern Toxicology, Department of Epidemiology and Biostatistics, School of Public Health, Nanjing Medical University, Nanjing, China, Section of Clinical Epidemiology, Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Cancer Center, Nanjing Medical University, Nanjing, China

  ⨯
• Guangfu Jin,

  Affiliations State Key Laboratory of Reproductive Medicine, Institute of Toxicology, Nanjing Medical University, Nanjing, China, MOE Key Laboratory of Modern Toxicology, Department of Epidemiology and Biostatistics, School of Public Health, Nanjing Medical University, Nanjing, China, Section of Clinical Epidemiology, Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Cancer Center, Nanjing Medical University, Nanjing, China

  ⨯
• Zhibin Hu,

  Affiliations State Key Laboratory of Reproductive Medicine, Institute of Toxicology, Nanjing Medical University, Nanjing, China, MOE Key Laboratory of Modern Toxicology, Department of Epidemiology and Biostatistics, School of Public Health, Nanjing Medical University, Nanjing, China, Section of Clinical Epidemiology, Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Cancer Center, Nanjing Medical University, Nanjing, China

  ⨯
• Xiaoxiang Guan ,

  * E-mail: hbshen@njmu.edu.cn (HS); xxguan@hotmail.com (XG)

  Affiliation Department of Medical Oncology, Jinling Hospital, Southern Medical University, Nanjing, China

  ⨯
• Hongbing Shen

  * E-mail: hbshen@njmu.edu.cn (HS); xxguan@hotmail.com (XG)

  Affiliations State Key Laboratory of Reproductive Medicine, Institute of Toxicology, Nanjing Medical University, Nanjing, China, MOE Key Laboratory of Modern Toxicology, Department of Epidemiology and Biostatistics, School of Public Health, Nanjing Medical University, Nanjing, China, Section of Clinical Epidemiology, Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Cancer Center, Nanjing Medical University, Nanjing, China

  ⨯